SCHEMBL2908635

SCHEMBL2908635

Cc1oc2c(C)c(C)c(NCc3ccc(F)cc3)c(C)c2c1-c1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 3/20 0.35
GAA P10253 3/20 0.35
CYP1A2 P05177 2/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
HTT P42858 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35
CYP2C19 P33261 1/20 0.35
GFER P55789 1/20 0.35
PTGS2 P35354 2/20 0.34
AURKA O14965 1/20 0.34
ABL1 P00519 1/20 0.34
NTRK1 P04629 1/20 0.34
LCK P06239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913685 0.94 MAPT (0.38) LMNAALDH1A1GAAKDM4EMEN1
SCHEMBL2938540 0.92 MAPT (0.41) LMNAGAAMEN1HTTKMT2A
SCHEMBL2907284 0.92 MEN1 (0.37) THRBLMNAALDH1A1GAACYP1A2
Hydrochloric Acid SCHEMBL2911758 0.79 MAPT (0.42) LMNAALDH1A1GAACYP1A2KDM4E
SCHEMBL2947795 0.75 ADCY1 (0.44) LMNAKDM4EMEN1KMT2ATSHR
SCHEMBL4036180 0.74 PTGS2 (0.37) ALDH1A1GAACYP1A2KDM4EMEN1
Hydrochloric Acid SCHEMBL4039957 0.72 PTGS2 (0.36) ALDH1A1GAACYP1A2KDM4EMEN1
SCHEMBL2940746 0.70 KDM4E (0.44) ALDH1A1CYP1A2KDM4EMEN1HTT
SCHEMBL2913204 0.69 ADCY1 (0.39) LMNAGAAKDM4EMAPTRAB9A
SCHEMBL13791048 0.63 PTGS2 (0.41) LMNAALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481679-B1 ANTIDEPRESSANT TAKEDA PHARMACEUTICAL (JP) 2010-08-25 EP claimed
EP-2069229-A1 METHOD FOR NANOPARTICLE SURFACE MODIFICATION 3M Innovative Properties Company (US) 2009-06-17 EP claimed
EP-1323716-B1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS TAKEDA PHARMACEUTICAL (JP) 2009-01-14 EP claimed
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2009-01-08 US claimed
US-7456162-B2 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-25 US claimed
US-20080069887-A1 Method for nanoparticle surface modification 3M INNOVATIVE PROPERTIES COMPANY 2008-03-20 US claimed
WO-2008033718-A1 METHOD FOR NANOPARTICLE SURFACE MODIFICATION 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-03-20 WO claimed
US-20060241168-A1 Antidepressant OHKAWA SHIGENORI 2006-10-26 US claimed
US-20050187238-A1 Benzofuran derivatives, their production and use OHKAWA SHIGENORI (JP) 2005-08-25 US claimed
CN-1638763-A antidepressants TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-07-13 CN claimed
EP-1136477-B1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-03-10 EP claimed
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-02-19 US claimed
EP-1323716-A1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS Takeda Chemical Industries, Ltd. (JP) 2003-07-02 EP claimed
US-20020160996-A1 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2002-10-31 US claimed
EP-1136477-A1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-26 EP claimed
EP-1481679-B1 ANTIDEPRESSANT TAKEDA PHARMACEUTICAL (JP) 2010-08-25 EP disclosed
US-7750037-B2 Antidepressant TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-06 US disclosed
US-6479536-B1 Benzofuran derivatives, process for the preparation of the same and uses thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-11-12 US disclosed
US-20020160996-A1 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2002-10-31 US disclosed
EP-1136477-A1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241168-A1 Antidepressant AKT1S1, AKT1, AKT2 THRB 171/4885LMNA 1435/4885ALDH1A1 3081/4885
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells NES, MKI67, CCNO THRB 753/4885LMNA 1938/4885ALDH1A1 359/4885
US-20050187238-A1 Benzofuran derivatives, their production and use WDR1, WDR82, CBR1 THRB 1851/4885LMNA 1075/4885ALDH1A1 735/4885
US-20080069887-A1 Method for nanoparticle surface modification MGMT, AS3MT, NCL THRB 4117/4885LMNA 2919/4885ALDH1A1 913/4885
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells NES, HAT1, PROX1 THRB 657/4885LMNA 1890/4885ALDH1A1 311/4885
US-20020160996-A1 Benzofuran derivatives, their production and use PARK7, WDR1, WHR1 THRB 2234/4885LMNA 972/4885ALDH1A1 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.